Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

日油

Nichi-Iko Pharmaceutical

KUMIAI CHEMICAL INDUSTRY

TOWA PHARMACEUTICAL

東京応化工業

積水樹脂

TOYO INK SC HOLDINGS

SAKATA INX

TENMA

SATO PHARMACEUTICAL

KANEKA

NATOCO

Noevir Holdings

NITTO FC

MANDOM

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

日本セラミック

日本セラミック

日本セラミック

日本セラミック

日本セラミック

Financial Indicator Details: TOWA PHARMACEUTICAL (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: TOWA PHARMACEUTICAL (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	10.50% (-12.05%)	11.78% (-0.50%)	12.66% (1.53%)	11.77% (-1.67%)	11.22% (3.05%)
C/F margin (Industry Average)	12.43% (-3.31%)	16.79% (8.51%)	12.43% (7.04%)	6.93% (6.35%)	15.64% (8.25%)
ROA (Industry Average)	7.83% (0.52%)	7.60% (1.04%)	8.01% (2.07%)	7.06% (0.06%)	6.91% (2.71%)
ROE (Industry Average)	9.92% (-1.43%)	10.96% (0.03%)	12.52% (2.96%)	11.36% (4.68%)	11.15% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	10.24% (5.01%)	11.25% (2.61%)	8.20% (-0.40%)	10.13% (8.16%)
Sales growth (Industry Average)	- (-)	8.55% (-2.67%)	18.19% (5.36%)	5.57% (1.07%)	13.38% (2.24%)
Net profit growth (Industry Average)	- (-)	21.81% (203.46%)	27.05% (63.25%)	-1.86% (3.89%)	8.08% (90.38%)
Operating C/F growth (Industry Average)	- (-)	46.63% (275.10%)	-12.47% (35.09%)	-41.12% (-6.09%)	155.84% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	78.86% (53.80%)	69.32% (54.51%)	63.95% (55.00%)	62.15% (53.59%)	61.99% (56.30%)
Liquidity ratio (Industry Average)	307.37% (217.72%)	277.90% (225.70%)	251.23% (237.55%)	213.07% (239.89%)	241.04% (236.21%)
C/F ratio current liabilities (Industry Average)	206.69% (777.21%)	206.80% (303.31%)	294.45% (434.79%)	586.74% (929.73%)	225.78% (573.30%)
Quick ratio (Industry Average)	181.92% (138.97%)	189.28% (148.85%)	151.22% (156.17%)	104.32% (160.84%)	106.06% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	141.08day (83.89day)	137.66day (94.27day)	126.74day (93.96day)	123.36day (97.92day)	113.75day (98.27day)
Inventory turnover (Industry Average)	95.75day (54.45day)	101.33day (52.58day)	106.61day (52.64day)	129.59day (56.59day)	129.96day (58.68day)
Payable turnover (Industry Average)	43.94day (45.01day)	54.52day (49.82day)	59.64day (49.52day)	64.59day (52.10day)	60.52day (51.12day)
Working capita turnover (Industry Average)	192.88day (93.32day)	184.48day (97.02day)	173.72day (97.08day)	188.36day (102.41day)	183.20day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	15.53% (34.57%)	-11.65% (1.49%)	-2.49% (-3.85%)	21.70% (21.16%)
Dividend Yield (Industry Average)	1.09% (3.20%)	0.94% (1.93%)	1.48% (2.17%)	1.82% (2.45%)	1.43% (2.07%)
PER (Industry Average)	18.73% (25.22%)	17.76% (23.06%)	12.35% (16.22%)	12.27% (29.19%)	13.81% (16.58%)
PBR (Industry Average)	1.85% (0.86%)	1.94% (1.06%)	1.54% (1.04%)	1.39% (0.95%)	1.54% (1.08%)
PCFR (Industry Average)	15.82% (7.18%)	12.46% (9.23%)	12.58% (-2.43%)	20.83% (9.50%)	9.91% (7.56%)
PSR (Industry Average)	1.96% (0.77%)	2.09% (0.88%)	1.56% (1.10%)	1.44% (0.90%)	1.55% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	10.62% (-27.66%)	11.95% (-4.34%)	12.69% (-5.37%)	12.06% (-10.69%)	11.35% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	7.78% (0.52%)	7.58% (0.92%)	7.97% (1.42%)	7.20% (-0.27%)	6.97% (1.53%)
ROE (Industry Average)	9.80% (-0.84%)	10.89% (-0.46%)	12.32% (1.81%)	11.41% (3.42%)	11.09% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	10.13% (3.64%)	10.96% (3.03%)	8.21% (0.04%)	10.03% (3.91%)
Sales growth (Industry Average)	- (-)	8.72% (-3.48%)	18.35% (6.70%)	5.46% (0.75%)	13.55% (-1.74%)
Net profit growth (Industry Average)	- (-)	22.40% (166.48%)	25.59% (43.48%)	0.22% (-47.04%)	6.93% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	79.46% (56.79%)	69.66% (57.65%)	64.70% (57.17%)	63.07% (55.93%)	62.85% (57.57%)
Liquidity ratio (Industry Average)	310.08% (337.22%)	278.61% (276.75%)	261.31% (266.94%)	215.23% (314.47%)	249.28% (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	181.69% (167.28%)	189.23% (183.78%)	156.18% (174.83%)	103.21% (228.06%)	107.34% (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	139.87day (87.55day)	136.65day (98.39day)	125.47day (95.88day)	121.18day (98.58day)	111.22day (67.18day)
Inventory turnover (Industry Average)	97.43day (50.17day)	102.90day (48.43day)	108.27day (47.43day)	132.08day (50.67day)	131.89day (38.21day)
Payable turnover (Industry Average)	46.82day (45.70day)	54.83day (51.63day)	60.14day (51.13day)	64.79day (53.57day)	59.90day (34.24day)
Working capita turnover (Industry Average)	190.48day (92.02day)	184.72day (95.19day)	173.60day (92.19day)	188.47day (95.69day)	183.22day (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	15.53% (34.46%)	-11.65% (3.11%)	-2.49% (-3.30%)	21.70% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	19.13% (34.12%)	18.06% (27.80%)	12.70% (13.58%)	12.36% (22.26%)	14.06% (26.42%)
PBR (Industry Average)	1.87% (0.97%)	1.96% (1.21%)	1.56% (1.17%)	1.41% (1.08%)	1.56% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	2.03% (3.42%)	2.16% (4.34%)	1.61% (3.67%)	1.49% (4.37%)	1.59% (10.14%)

Financial Indicator Details: TOWA PHARMACEUTICAL

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	10.50%	11.78%	12.66%	11.77%	11.22%
C/F margin	12.43%	16.79%	12.43%	6.93%	15.64%
ROA	7.83%	7.60%	8.01%	7.06%	6.91%
ROE	9.92%	10.96%	12.52%	11.36%	11.15%
Recurring margin	18.57%	19.03%	20.36%	20.19%	17.27%
EBIT margin	17.27%	18.80%	20.54%	20.10%	16.96%
EBITDA margin	22.39%	23.38%	24.60%	25.51%	25.84%
NOPAT margin	10.36%	11.28%	12.32%	12.06%	10.17%
Sales SG rates	51.00%	48.13%	46.26%	45.12%	49.78%
Sales SG&A rates	31.17%	32.02%	32.81%	36.17%	36.23%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	5.12%	4.57%	4.05%	5.41%	8.88%
Capital expenditures net sales ratio	-7.80%	-5.98%	-18.62%	-18.49%	-19.05%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	275.62%	-12.88%	-55.75%	-17.35%
Equity growth	-	10.24%	11.25%	8.20%	10.13%
Total assets growth	-	25.42%	20.59%	11.34%	10.41%
Sales growth	-	8.55%	18.19%	5.57%	13.38%
Net profit growth	-	21.81%	27.05%	-1.86%	8.08%
Operating C/F growth	-	46.63%	-12.47%	-41.12%	155.84%
Recurring profit growth	-	11.18%	26.46%	4.73%	-3.01%
EBIT growth	-	18.17%	29.10%	3.30%	-4.31%
EBITDA growth	-	13.32%	24.34%	9.48%	14.87%
NOPAT growth	-	18.17%	29.10%	3.30%	-4.31%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	78.86%	69.32%	63.95%	62.15%	61.99%
Liquidity ratio	307.37%	277.90%	251.23%	213.07%	241.04%
C/F ratio current liabilities	206.69%	206.80%	294.45%	586.74%	225.78%
Quick ratio	181.92%	189.28%	151.22%	104.32%	106.06%
Fixed ratio	43.10%	46.97%	57.50%	69.79%	68.32%
D/E ratio	-	9.53%	19.92%	23.96%	29.01%
Loan to Value Ratio	-	6.61%	12.74%	14.89%	17.98%
Business investment C/F ratio	-62.81%	-35.65%	-149.74%	-266.61%	-121.73%
Liabilities with interest growth	-	-	132.50%	30.09%	33.34%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	29.55day	102.28day	75.38day	31.59day	23.02day
Receivables turnover	141.08day	137.66day	126.74day	123.36day	113.75day
Inventory turnover	95.75day	101.33day	106.61day	129.59day	129.96day
Fixed assets turnover	166.42day	184.18day	212.24day	264.03day	251.06day
Total asset turnover	489.53day	565.63day	577.13day	608.67day	592.71day
Payable turnover	43.94day	54.52day	59.64day	64.59day	60.52day
Capital turnover	47.87day	44.09day	37.31day	35.33day	31.16day
Equity turnover	386.09day	392.12day	369.10day	378.29day	367.43day
Working capita turnover	192.88day	184.48day	173.72day	188.36day	183.20day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 2 B	¥ 10 B	¥ 9 B	¥ 4 B	¥ 3 B
Accounts receivable-trade	¥ 13 B	¥ 14 B	¥ 16 B	¥ 16 B	¥ 17 B
Other Current Assets	¥ 25 B	¥ 26 B	¥ 32 B	¥ 38 B	¥ 43 B
Current Assets	¥ 28 B	¥ 37 B	¥ 42 B	¥ 42 B	¥ 47 B
Tangible Assets	¥ 16 B	¥ 19 B	¥ 26 B	¥ 35 B	¥ 37 B
Intangible Assets	¥ 229 M	¥ 369 M	¥ 606 M	¥ 774 M	¥ 768 M
Investment etc.	¥ 3 B	¥ 2 B	¥ 3 B	¥ 2 B	¥ 3 B
Total Assets	¥ 48 B	¥ 60 B	¥ 72 B	¥ 81 B	¥ 89 B
Current Liabilities	¥ 9 B	¥ 13 B	¥ 16 B	¥ 19 B	¥ 19 B
Fixed Liabilities	¥ 950 M	¥ 4 B	¥ 9 B	¥ 10 B	¥ 14 B
Liabilities with interest	-	¥ 4 B	¥ 9 B	¥ 12 B	¥ 16 B
Net Assets	¥ 38 B	¥ 41 B	¥ 46 B	¥ 50 B	¥ 55 B
Capital stock	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B
Capital surplus etc.	¥ 33 B	¥ 37 B	¥ 41 B	¥ 45 B	¥ 50 B
Liabilities and net assets	¥ 48 B	¥ 60 B	¥ 72 B	¥ 81 B	¥ 89 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 35 B	¥ 39 B	¥ 46 B	¥ 48 B	¥ 55 B
Cost of Sales	¥ 18 B	¥ 18 B	¥ 21 B	¥ 21 B	¥ 27 B
Gross profit	¥ 17 B	¥ 20 B	¥ 24 B	¥ 26 B	¥ 27 B
Other income	¥ 633 M	¥ 206 M	¥ 376 M	¥ 849 M	¥ 2 B
SG&A	¥ 11 B	¥ 12 B	¥ 15 B	¥ 17 B	¥ 20 B
Other expenses	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B	¥ 3 B
Net income	¥ 3 B	¥ 4 B	¥ 5 B	¥ 5 B	¥ 6 B
Operating income	¥ 6 B	¥ 7 B	¥ 9 B	¥ 9 B	¥ 7 B
Ordinary Income	¥ 6 B	¥ 7 B	¥ 9 B	¥ 9 B	¥ 9 B
EBITDA	¥ 8 B	¥ 9 B	¥ 11 B	¥ 12 B	¥ 14 B
Income before income taxes	¥ 6 B	¥ 7 B	¥ 9 B	¥ 9 B	¥ 9 B
Depreciation	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B	¥ 4 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 4 B	¥ 6 B	¥ 5 B	¥ 3 B	¥ 8 B
Investment CF	¥ -2 B	¥ -7 B	¥ -7 B	¥ -8 B	¥ -11 B
Financial CF	¥ -772 M	¥ 3 B	¥ 4 B	¥ 879 M	¥ 2 B
Foreign Exchange Effects	¥ 30 M	¥ 16 M	¥ -16 M	¥ -9 M	¥ 46 M
Net Change in Cash	¥ 1 B	¥ 2 B	¥ 2 B	¥ -4 B	¥ 187 M
Free CF	¥ 1 B	¥ -723 M	¥ -2 B	¥ -5 B	¥ -2 B
Capital expenditures	¥ -2 B	¥ -2 B	¥ -8 B	¥ -9 B	¥ -10 B
Cash dividends paid	¥ -771 M	¥ -775 M	¥ -1 B	¥ -1 B	¥ -1 B
Repayment loans	-	-	-	¥ -700 M	¥ -2 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -772 M	¥ -772 M	¥ -1 B	¥ -1 B	¥ -1 B
Net income	¥ 3 B	¥ 4 B	¥ 5 B	¥ 5 B	¥ 6 B
Purchase of treasury stock	¥ -858 K	¥ -1 M	-	¥ -627 M	-
Other Change in Stockholders Equity	-	-	¥ -1 M	-	-
Other Change in Net Assets	¥ 103 M	¥ 71 M	¥ -55 M	¥ 7 M	¥ 147 M
Net Change in Net Assets	¥ 3 B	¥ 3 B	¥ 4 B	¥ 3 B	¥ 5 B

Financial Indicator Details: TOWA PHARMACEUTICAL

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	10.62%	11.95%	12.69%	12.06%	11.35%
C/F margin	-	-	-	-	-
ROA	7.78%	7.58%	7.97%	7.20%	6.97%
ROE	9.80%	10.89%	12.32%	11.41%	11.09%
Recurring margin	18.74%	19.21%	20.40%	20.68%	17.45%
EBIT margin	17.50%	19.04%	20.56%	20.59%	17.19%
EBITDA margin	17.97%	19.41%	21.06%	21.36%	18.51%
NOPAT margin	10.50%	11.42%	12.34%	12.35%	10.31%
Sales SG rates	51.14%	48.11%	46.34%	44.62%	49.55%
Sales SG&A rates	30.98%	31.84%	32.69%	36.26%	36.38%
Sales R&D expenses rates	6.65%	6.74%	7.23%	8.59%	8.30%
Sales depreciation rates	0.46%	0.37%	0.49%	0.77%	1.31%
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	287.75%	-13.39%	-58.43%	-14.38%
Equity growth	-	10.13%	10.96%	8.21%	10.03%
Total assets growth	-	25.63%	19.48%	11.00%	10.42%
Sales growth	-	8.72%	18.35%	5.46%	13.55%
Net profit growth	-	22.40%	25.59%	0.22%	6.93%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	11.45%	25.64%	6.90%	-4.19%
EBIT growth	-	18.23%	27.85%	5.59%	-5.19%
EBITDA growth	-	17.39%	28.44%	6.97%	-1.63%
NOPAT growth	-	18.23%	27.85%	5.59%	-5.19%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	79.46%	69.66%	64.70%	63.07%	62.85%
Liquidity ratio	310.08%	278.61%	261.31%	215.23%	249.28%
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	181.69%	189.23%	156.18%	103.21%	107.34%
Fixed ratio	41.15%	45.44%	54.85%	67.45%	65.78%
D/E ratio	-	9.62%	19.52%	22.04%	27.56%
Loan to Value Ratio	-	6.70%	12.63%	13.90%	17.32%
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-	125.00%	22.21%	37.58%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	29.14day	103.94day	76.06day	29.98day	22.60day
Receivables turnover	139.87day	136.65day	125.47day	121.18day	111.22day
Inventory turnover	97.43day	102.90day	108.27day	132.08day	131.89day
Fixed assets turnover	162.82day	182.09day	206.10day	260.07day	245.78day
Total asset turnover	497.80day	575.23day	580.71day	611.24day	594.40day
Payable turnover	46.82day	54.83day	60.14day	64.79day	59.90day
Capital turnover	49.48day	45.50day	38.44day	36.45day	32.10day
Equity turnover	395.59day	400.73day	375.72day	385.55day	373.63day
Working capita turnover	190.48day	184.72day	173.60day	188.47day	183.22day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 2 B	¥ 10 B	¥ 9 B	¥ 3 B	¥ 3 B
Accounts receivable-trade	¥ 13 B	¥ 14 B	¥ 15 B	¥ 15 B	¥ 16 B
Other Current Assets	¥ 24 B	¥ 25 B	¥ 32 B	¥ 36 B	¥ 42 B
Current Assets	¥ 27 B	¥ 36 B	¥ 41 B	¥ 40 B	¥ 45 B
Tangible Assets	¥ 15 B	¥ 18 B	¥ 25 B	¥ 33 B	¥ 36 B
Intangible Assets	¥ 227 M	¥ 366 M	¥ 604 M	¥ 756 M	¥ 755 M
Investment etc.	¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B
Total Assets	¥ 47 B	¥ 59 B	¥ 71 B	¥ 79 B	¥ 87 B
Current Liabilities	¥ 8 B	¥ 13 B	¥ 15 B	¥ 18 B	¥ 18 B
Fixed Liabilities	¥ 875 M	¥ 4 B	¥ 9 B	¥ 10 B	¥ 14 B
Liabilities with interest	-	¥ 4 B	¥ 9 B	¥ 10 B	¥ 15 B
Net Assets	¥ 37 B	¥ 41 B	¥ 46 B	¥ 49 B	¥ 54 B
Capital stock	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B
Capital surplus etc.	¥ 32 B	¥ 36 B	¥ 41 B	¥ 45 B	¥ 50 B
Liabilities and net assets	¥ 47 B	¥ 59 B	¥ 71 B	¥ 79 B	¥ 87 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 34 B	¥ 37 B	¥ 44 B	¥ 47 B	¥ 53 B
Cost of Sales	¥ 17 B	¥ 18 B	¥ 20 B	¥ 21 B	¥ 26 B
Gross profit	¥ 17 B	¥ 19 B	¥ 24 B	¥ 26 B	¥ 27 B
Other income	¥ 645 M	¥ 213 M	¥ 382 M	¥ 856 M	¥ 2 B
SG&A	¥ 10 B	¥ 12 B	¥ 14 B	¥ 17 B	¥ 19 B
Other expenses	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B	¥ 3 B
Net income	¥ 3 B	¥ 4 B	¥ 5 B	¥ 5 B	¥ 6 B
Operating income	¥ 6 B	¥ 7 B	¥ 9 B	¥ 9 B	¥ 7 B
Ordinary Income	¥ 6 B	¥ 7 B	¥ 9 B	¥ 9 B	¥ 9 B
EBITDA	¥ 6 B	¥ 7 B	¥ 9 B	¥ 10 B	¥ 9 B
Income before income taxes	¥ 6 B	¥ 7 B	¥ 9 B	¥ 9 B	¥ 9 B
Depreciation	¥ 162 M	¥ 140 M	¥ 222 M	¥ 365 M	¥ 705 M
R&D expenses	¥ 2 B	¥ 2 B	¥ 3 B	¥ 4 B	¥ 4 B
Income taxes	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -772 M	¥ -772 M	¥ -1 B	¥ -1 B	¥ -1 B
Net income	¥ 3 B	¥ 4 B	¥ 5 B	¥ 5 B	¥ 6 B
Purchase of treasury stock	¥ -858 K	¥ -1 M	-	¥ -627 M	-
Other Change in Stockholders Equity	-	-	¥ -1 M	-	-
Other Change in Net Assets	¥ 103 M	¥ 71 M	¥ -55 M	¥ 7 M	¥ 147 M
Net Change in Net Assets	¥ 3 B	¥ 3 B	¥ 4 B	¥ 3 B	¥ 5 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: TOWA PHARMACEUTICAL (Annual )

Statement Type

Annual : TOWA PHARMACEUTICAL

First quarter : TOWA PHARMACEUTICAL

Second quarter : TOWA PHARMACEUTICAL

Third quarter : TOWA PHARMACEUTICAL

Analysis Menu

Outline : TOWA PHARMACEUTICAL

Statement : TOWA PHARMACEUTICAL

Rating : TOWA PHARMACEUTICAL

Indicator : TOWA PHARMACEUTICAL

Download : TOWA PHARMACEUTICAL

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Osaka - EDIUNET Prefectures

Osaka門真市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
TOWA PHARMACEUTICAL	4553	TSE 1st	Chemicals	3	Annual	BBB

Related Company

NATOCO (Sales ¥ 16 B)

TOWA PHARMACEUTICAL (Sales ¥ 55 B)

SAWAI PHARMACEUTICAL (Sales ¥ 80 B)

Nichi-Iko Pharmaceutical (Sales ¥ 93 B)

kyowa Hakko Kirin (Sales ¥ 333 B)

Sumitomo Bakelite (Sales ¥ 183 B)

KANEKA (Sales ¥ 476 B)

東京応化工業 (Sales ¥ 72 B)

Dr.Ci:Labo (Sales ¥ 33 B)

NITTO FC (Sales ¥ 18 B)

小林製薬 (Sales ¥ 121 B)

日油 (Sales ¥ 148 B)

KUMIAI CHEMICAL INDUSTRY (Sales ¥ 49 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .